Manitoba Heritage Theses

Permanent URI for this collection

http://hdl.handle.net/1993/3098
Contains full text Manitoba-related theses dating from 1902 to the present.

The University of Manitoba Libraries gratefully acknowledges the financial support of the Manitoba Department of Heritage, Culture, Tourism and Sport in the digitization of many of these theses.

Browse

Browsing Manitoba Heritage Theses by Subject "16s rRNA"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Open Access
    Gut microbiome in immune-mediated inflammatory disease
    (Wolters Kluwer, 2016) Forbes, Jessica Dawn; Alfa, Michelle (Medical Microbiology and Infectious Diseases) Bernstein, Charles (Internal Medicine) de Kievit, Teresa (Microbiology) Surette, Michael (McMaster University); Van Domselaar, Gary (Medical Microbiology and Infectious Diseases)
    Immune-mediated inflammatory diseases (IMID) represent a group of ostensibly unrelated, chronic and highly disabling diseases that preferentially affect different organ systems. IMID are assumed to manifest as a result of the accumulation of genetic, environmental and immunological factors. A fundamental commonality between IMID is the idiopathic nature of disease, and moreover, substantial similarities are apparent in disease etiopathogenesis. The complex assemblage of microbes and their genes that exists within and on the human body, collectively known as the microbiome has emerged as a critical factor in human health and, altered microbial populations within the gastrointestinal tract lumen and mucosa have been linked to several IMID. Accordingly, we conducted several studies investigating the association of the gut microbiome with IMID. Our main study investigated differences in the microbial profile and functional potential of multiple IMID utilizing 16S rDNA amplicon sequencing and analysis of stool. We also investigated the mucosal-associated microbiome in IBD to characterize the microbial populations and their functions residing in distinct gastrointestinal compartments from inflamed and noninflamed mucosa. We also explored a potential environmental factor; specifically assessing whether microbes present in drinking water in low or high incidence areas of IBD might contribute to disease etiology. The findings of these studies are manifold. First, we show important differences of the stool microbial profile in IMID. In doing so, we were able to identify distinct states of gut dysbiosis and have revealed numerous microbes that are consistently or uniquely disproportionate between IMID. Second, we have shown the microbial profile associated with inflamed and noninflamed mucosa and have reported that a localized dysbiosis is not observed in the presence of inflammation. Third, we have revealed that distinct gastrointestinal compartments are comprised of similar microbial communities. Lastly, we have reported the drinking water microbiome to differ between low and high incidence areas of IBD, thus suggesting a potential role in IBD etiology. Understanding the role of the gut microbiome in human disease will enable the development and application of more appropriate therapeutic strategies that specifically target microbes within the gut.